Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway

被引:122
作者
Bond, M
Murphy, G
Bennett, MR
Newby, AC
Baker, AH
机构
[1] Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Bristol BS2 8HW, Avon, England
[2] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England
[3] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[4] Univ Glasgow, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland
关键词
D O I
10.1074/jbc.M111507200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tissue inhibitors of metalloproteinases (TIMPs) are important regulators of matrix metalloproteinase (MMP) and adamalysin metalloproteinase activity. We previously reported that overexpression of TIMP-3 inhibits MMPs and induces apoptotic cell death in a variety of cell types and demonstrated that apoptosis is mediated through the N terminus of TIMP-3, which harbors the MMP inhibitory domain. However, little is known about the mechanisms underlying TIMP-3-induced apoptosis. Here we demonstrate that overexpression of TIMP-3 induced activation of initiator caspase-8 and -9 and promoted caspase-mediated cleavage of the death substrates poly(ADP-ribose) polymerase and focal adhesion kinase. Furthermore, TIMP-3 induced mitochondrial activation as demonstrated by loss of mitochondrial membrane potential and release of cytochrome c. Intervention studies demonstrated that overexpression of Bcl-2, the anti-apoptotic mitochondrial membrane protein, or CrmA, a viral serpin inhibitor of caspase-8, completely inhibited TIMP-3-induced apoptosis. Furthermore, a dominant-negative Fas-associated death domain mutant inhibited TIMP-3-induced death substrate cleavage and apoptotic death. Taken together, these results indicate that TIMP-3 overexpression induces a type II apoptotic pathway initiated via a Fas-associated death domain-dependent mechanism.
引用
收藏
页码:13787 / 13795
页数:9
相关论文
共 61 条
[1]   Life-or-death decisions by the Bcl-2 protein family [J].
Adams, JM ;
Cory, S .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (01) :61-66
[2]  
Ahonen M, 2000, J INVEST DERMATOL, V115, P575
[3]  
Ahonen M, 1998, CANCER RES, V58, P2310
[4]   TNF-α converting enzyme (TACE) is inhibited by TIMP-3 [J].
Amour, A ;
Slocombe, PM ;
Webster, A ;
Butler, M ;
Knight, CG ;
Smith, BJ ;
Stephens, PE ;
Shelley, C ;
Hutton, M ;
Knäuper, V ;
Docherty, AJP ;
Murphy, G .
FEBS LETTERS, 1998, 435 (01) :39-44
[5]   A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth [J].
AnandApte, B ;
Bao, L ;
Smith, R ;
Iwata, K ;
Olsen, BR ;
Zetter, B ;
Apte, SS .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1996, 74 (06) :853-862
[6]   The Bcl-2 protein family [J].
Antonsson, B ;
Martinou, JC .
EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) :50-57
[7]   CLONING OF THE CDNA-ENCODING HUMAN TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP-3) AND MAPPING OF THE TIMP3 GENE TO CHROMOSOME-22 [J].
APTE, SS ;
MATTEI, MG ;
OLSEN, BR .
GENOMICS, 1994, 19 (01) :86-90
[8]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[9]   Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3 [J].
Baker, AH ;
George, SJ ;
Zaltsman, AB ;
Murphy, G ;
Newby, AC .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1347-1355
[10]   Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro - TIMP-3 promotes apoptosis [J].
Baker, AH ;
Zaltsman, AB ;
George, SJ ;
Newby, AC .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (06) :1478-1487